Hey Hyper, yep still around, and also in cyrx yet...
The way I've been analyzing atrs is off others numbers, seems to be a number very well educated retail investors here. Investor village has a member tracking script numbers weekly and smithonstocks keeps updated his analysis to name a couple.
Your numbers appear very plausible in comparison. The way I see it, the market is very skeptical of atrs, if it was only retail in control I think we would be valued higher. We have a 500m market cap with huge revenue growth likely coming next few quarters, growth bios usually command a huge multiple but we sit at 5x this fiscal year projected revs. Look at cryoport, its not worth 500m imo, but the market thinks so(yes I do hold all my shares yet, but sold nov $20 covered calls last week on a quarter of'em).
Right now, at this time in the market, many stocks are priced too high imo. Atrs however has had little appreciation shown for xyo, which will be telling very soon. The other indicator I like recently is they doubled their credit facility vs doing a secondary. I like to think it shows management is confident in the future rev and bottom line. My 12 month target is 6 to 8 bucks...could be conservative if epi jr and forteo do well.
News 
Market Data 
Discover 
AI
